Company Financials

Hebei Changshan Biochemical Pharmaceutical Co. Ltd Financials

Renminbi

business Hebei Changshan Biochemical Pharmaceutical Co. Ltd Company Profile

Main Stock Listing

SZSE: 300255

Market Capitalization CN¥56.50 Billion as of Jan. 1, 2026

Market Cap History

Valuations Metrics as of Jan. 3, 2026

Trailing PE -230.00
Forward PE
Price to Sales TTM CN¥61.50
Price to Book MRQ CN¥37.61
Enterprise to Revenue 63.98
Enterprise to EBITDA -486.28

Financial Reports as of Jun. 30, 2025

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter 2025-06-30
Profit Margin -32.50%
Operating Margin -4.48%
Return on Assets TTM -2.57%
Return on Equity TTM -18.04%

Income Statement

Revenue TTM CN¥928,010,112
Revenue per Share TTM CN¥0.88
Quarterly Revenue Growth -12.30%
Gross Profit TTM CN¥60,306,492
EBITDA CN¥8,897,266
Net Income to Common TTM CN¥-301,585,216
Diluted EPS TTM CN¥-0.33
Quarterly Earnings Growth YoY -14.83%

Balance Sheet

Total Cash MRQ CN¥247,912,848
Total Cash per Share MRQ CN¥0.27
Total Debt MRQ CN¥
Total Debt to Equity MRQ 175.01
Current Ratio MRQ 0.87
Book Value per Share MRQ CN¥1.65

Cash Flow

Operating Cash Flow TTM CN¥48,222,288
Levered Free Cash Flow TTM CN¥-72,501,072

300255 Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding 919,060,878
Float Shares 562,373,351
Avg 10 Volume 11,888,821
Avg 30 Volume None
Shares Short None
Short Ratio
Short % of Shares %
% Held by Insiders 37.01%
% Held by Institutions 0.50%

Stock Price Summary

Beta 0.24
Fifty Two Week Low CN¥15.75
Fifty Two Week High CN¥71.71
Fifty Two Week Change 69.07%
Day 50 MA CN¥60.84
Day 200 MA CN¥44.60

Dividends and Splits

Forward Annual Dividend Rate CN¥
Forward Annual Dividend Yield %
Trailing Annual Dividend Rate CN¥0.00
Trailing Annual Dividend Yield 0.00%
Payout Ratio 0.00%
Dividend Date
Ex Dividend Date 2023-06-27
Last Split Factor
Last Split Date 2016-04-20